PT1560819E - Derivados cristalinos dos canabinóides e processo de purificação dos canabinóides - Google Patents

Derivados cristalinos dos canabinóides e processo de purificação dos canabinóides Download PDF

Info

Publication number
PT1560819E
PT1560819E PT03781830T PT03781830T PT1560819E PT 1560819 E PT1560819 E PT 1560819E PT 03781830 T PT03781830 T PT 03781830T PT 03781830 T PT03781830 T PT 03781830T PT 1560819 E PT1560819 E PT 1560819E
Authority
PT
Portugal
Prior art keywords
cannabinoid
thc
purification
esters
crystalline derivatives
Prior art date
Application number
PT03781830T
Other languages
English (en)
Portuguese (pt)
Inventor
John R Duchek
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of PT1560819E publication Critical patent/PT1560819E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
PT03781830T 2002-11-12 2003-11-06 Derivados cristalinos dos canabinóides e processo de purificação dos canabinóides PT1560819E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42554302P 2002-11-12 2002-11-12
US43502702P 2002-12-20 2002-12-20

Publications (1)

Publication Number Publication Date
PT1560819E true PT1560819E (pt) 2008-11-03

Family

ID=32314593

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03781830T PT1560819E (pt) 2002-11-12 2003-11-06 Derivados cristalinos dos canabinóides e processo de purificação dos canabinóides

Country Status (13)

Country Link
US (1) US7402686B2 (enExample)
EP (1) EP1560819B1 (enExample)
JP (1) JP2006508132A (enExample)
AT (1) ATE410419T1 (enExample)
AU (1) AU2003287585B2 (enExample)
CA (1) CA2504743C (enExample)
DE (1) DE60324011D1 (enExample)
DK (1) DK1560819T3 (enExample)
ES (1) ES2315548T3 (enExample)
MX (1) MXPA05004966A (enExample)
PT (1) PT1560819E (enExample)
SI (1) SI1560819T1 (enExample)
WO (1) WO2004043946A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
WO2006007734A1 (de) * 2004-07-19 2006-01-26 Cilag Ltd. Verfahren zur gewinnung von reinem tetrahydrocannabinol
EA200701246A1 (ru) * 2004-12-09 2008-06-30 Инсис Терапьютикс, Инк. Стабильные при комнатной температуре составы дронабинола
AU2012201041B2 (en) * 2005-09-29 2012-12-06 Albany Molecular Research, Inc. Process for production of delta-9-tetrahydrocannabinol
EP2578577A1 (en) * 2005-09-29 2013-04-10 Albany Molecular Research, Inc. Sulfonyl esters of tetrahydrocannabinol and derivatives thereof
CA2659775A1 (en) * 2006-08-04 2008-02-14 Insys Therapeutics Inc. Aqueous dronabinol formulations
GB0702895D0 (en) * 2007-02-14 2007-03-28 Resolution Chemicals Ltd Delta 9 tetrahydrocannabinol derivatives
GB0703284D0 (en) 2007-02-20 2007-03-28 Resolution Chemicals Ltd Delta 9 - tetrahydrocannabinol processing
CA2698752A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
WO2009099868A1 (en) * 2008-02-06 2009-08-13 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US9539295B2 (en) 2014-12-05 2017-01-10 Bradley Michael Bohus Cannabidiol (CBD) enriched alcohol
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
GB201910389D0 (en) * 2019-07-19 2019-09-04 Gw Pharma Ltd Novel compounds, methods for their manufacture, and uses thereof
US11925907B2 (en) 2019-07-22 2024-03-12 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
WO2021055079A1 (en) 2019-09-16 2021-03-25 Vapor Cartridge Technology Llc Drug delivery system with stackable substrates
JP2023512578A (ja) * 2020-02-06 2023-03-27 ロンドン ファーマシューティカルズ アンド リサーチ コーポレーション Ｃアナビンオイド硫酸エステル、その塩及び用途
AU2022362107A1 (en) * 2021-10-11 2024-05-02 Anebulo Pharmaceuticals, Inc. Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507888A (en) 1966-08-30 1970-04-21 Searle & Co Process and intermediates for manufacture of 17-oxygenated estr-4-en-3-ones
US3728360A (en) 1971-08-31 1973-04-17 Little Inc A Ester derivatives of tetrahydrocannabinol
US4188495A (en) 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
US4206225A (en) 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4341906A (en) 1979-09-24 1982-07-27 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes
US4381399A (en) 1981-12-21 1983-04-26 Aerojet-General Corporation Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
GB9303911D0 (en) 1993-02-26 1993-04-14 Zeneca Ltd Chemical process
JP3384163B2 (ja) * 1994-11-09 2003-03-10 株式会社ニコン 顕微鏡対物レンズ
US6008383A (en) 1998-10-26 1999-12-28 University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol esters
WO2006000734A1 (en) 2004-06-23 2006-01-05 Bp P.L.C. The synthesis of the micro-porous silica gel and its application to the preparation of catalysts for c2 oxygenates synthesis from syngas

Also Published As

Publication number Publication date
AU2003287585A1 (en) 2004-06-03
EP1560819B1 (en) 2008-10-08
EP1560819A1 (en) 2005-08-10
WO2004043946A1 (en) 2004-05-27
ES2315548T3 (es) 2009-04-01
SI1560819T1 (sl) 2009-06-30
JP2006508132A (ja) 2006-03-09
US7402686B2 (en) 2008-07-22
DK1560819T3 (da) 2009-02-09
ATE410419T1 (de) 2008-10-15
AU2003287585B2 (en) 2009-05-07
US20060094774A1 (en) 2006-05-04
CA2504743A1 (en) 2004-05-27
DE60324011D1 (de) 2008-11-20
CA2504743C (en) 2012-04-24
MXPA05004966A (es) 2005-08-02

Similar Documents

Publication Publication Date Title
PT1560819E (pt) Derivados cristalinos dos canabinóides e processo de purificação dos canabinóides
NZ592897A (en) Crystals of laquinimod sodium, and process for the manufacture thereof
AU2002360559A1 (en) Reducing temperature differences within the regenerator of an oxygenate to olefin process
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
MY136761A (en) Oxazol derivatives
MY143958A (en) Quinazolinone derivatives and their use as cb agonists
IL165790A0 (en) Cationically substituted diphenyl azetidinones method for their production medicaments containing said compounds and use thereof
WO2006072458A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
MXPA04006803A (es) Derivados de acidos alfa-feniltiocarboxilicos y alfa-feniloxi-carboxilicos para tratamiento de enfermedades que responden a activacion del receptor alfa activado del proliferador de peroxisoma.
MY138698A (en) Method for synthesis of (2s)-indoline-2-carboxylic acid, and use in the synthesis of perindopril
NO20051047L (no) Fremgangsmate og mellomprodukter for fremstilling av tienopyrrolderivater
ATE397620T1 (de) Aufreinigungsverfahren, das eine mikrofiltration bei erhöhten temperaturen beinhaltet
EP1460997A4 (en) METHODS OF PURIFYING LEVOFLOXACIN
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MY136638A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
HK1039932A1 (zh) 使用馬杜拉二氮雜萘衍生物抑制前炎性細胞質變化
PL377232A1 (pl) Nowy proces syntezy kwasu (2S, 3aS, 7aS)-perhydroindolo-2- karboksylowego i jego estrów oraz zastosowanie w syntezie perindoprylu
MY136989A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
ATE286048T1 (de) Verfahren zur herstellung von carbostyril- derivaten
AU2002247949A1 (en) Process for synthesis of trans-alkenoic acid, use thereof